House Passes Bill to Bolster Drug Safety
Posted on: Thursday, 12 July 2007, 18:24 CDT
Both houses of the U.S. Congress have passed bills demanding stronger federal oversight of drug safety.
Legislation passed Wednesday by the U.S. House of Representatives significantly bolsters the Food and Drug Administration's resources and authority in ensuring the safety of drugs, The Los Angeles Times reported.
The legislation was prompted by federal investigations into the arthritis drug Vioxx. The medication was withdrawn in 2004 because of evidence that it caused heart attack and stroke. It had been on the market for five years.
Investigators found holes in the FDA drug approval process, including understaffing and a lack of post-market surveillance.
The drug safety provision is part of a bill that reauthorizes the collection of fees from drug manufacturers to finance the agency's drug approval process.
The language in the House bill appears stronger than similar legislation passed by the Senate, the Times said.
Both bills direct the agency to establish a computerized system to watch for possible health risks after drugs reach the market and to require that manufacturers include possible risks in drug packaging.
A compromise bill is expected before Congress's August recess, the Times said.
Source: United Press International
Related Articles
- SafeTScribe Technologies' Low Cost Time and Temperature Sensing Ink Enhances Food and Drug Safety and Quality Assurance
- Bush Signs Drug Safety Bill Into Law
- Pelosi: 'Today's Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans'
- House Vote Set Wednesday on First Major Prescription Drug Safety Improvements in Nearly Half Century
- Major Drug Safety Bill Passes U.S. Senate
- Pharmaceutical Companies Expanding Post-Market Drug Safety Initiatives to Prevent Adverse Reactions, Finds PricewaterhouseCoopers Study
- Senators plan bill to revamp FDA drug safety
- A Drug-Safety Board
- FDA Drug Approval Times Likely to Grow
 |
 |
User Comments (0)
RSS Feeds